Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.14%
1,102.18
+1.57
+0.14%
—1,100.611,106.151,114.281,098.89——
SIXC
Communications
SIXC
Communications
SIXC
+0.64%
616.24
+3.94
+0.64%
—612.30612.30616.40612.30——
SIXE
Energy
SIXE
Energy
SIXE
+1.21%
1,189.72
+14.26
+1.21%
—1,175.461,182.971,193.951,182.97——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.20%
1,725.69
-3.43
-0.20%
—1,729.121,731.371,754.071,718.58——
SIXM
Financials
SIXM
Financials
SIXM
-0.17%
643.62
-1.11
-0.17%
—644.73645.31649.16642.15——
SIXR
Staples
SIXR
Staples
SIXR
+0.33%
829.79
+2.70
+0.33%
—827.09828.05833.90827.27——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.66%
213.40
-1.42
-0.66%
—214.82214.82216.61212.62——
SIXT
Technology
SIXT
Technology
SIXT
+2.27%
3,185.92
+70.75
+2.27%
—3,115.173,142.773,186.203,133.07——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.16%
908.94
-1.49
-0.16%
—910.43915.18923.94906.03——
SIXV
Health care
SIXV
Health care
SIXV
+0.30%
1,478.96
+4.46
+0.30%
—1,474.501,480.841,491.461,475.55——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.02%
2,405.36
-0.51
-0.02%
—2,405.872,415.572,420.792,398.99——
GRF:BME
Grifols SA Class A
€9.19
-0.02%
(-0.0020) 1D
Apr 22, 5:36:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GRF...
Open
€9.19
High
€9.19
Low
€9.05
Mkt. cap
5.69B
Avg. vol.
2.72M
Volume
2.53M
Dividend
1.63%
Quarterly dividend
€0.04
Ex dividend date
Aug 11, 2025
P/E ratio
15.56
52-wk high
€13.70
52-wk low
€8.01
EPS
€0.59
Shares outstanding
426.13M
No. of employees
25K
News stories
From sources across the web
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A
CEONacho Abia
Employees25.3K
FoundedNov 18, 1940
Headquarters-
SectorBiotechnology
Websitegrifols.com
Last report
Feb 26, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-/ -EUR
Revenue / Estimate
1.98B/ (1.96B est.)EUR
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.79B
1.89B
1.87B
1.98B
Cost of goods sold
1.08B
1.15B
1.11B
1.28B
Cost of revenue
1.08B
1.15B
1.11B
1.28B
Research and development expenses
96.05M
96.19M
97.01M
90.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
315.37M
298.06M
273.76M
262.86M
Operating expense
411.42M
394.25M
370.34M
353.11M
Total operating expenses
1.49B
1.54B
1.48B
1.63B
Operating income
293.22M
349.54M
381.18M
347.38M
Other non operating income
-
8.08M
-
-33.00M
EBT including unusual items
115.26M
190.51M
198.13M
111.10M
EBT excluding unusual items
134.52M
190.51M
227.20M
183.10M
Income tax expense
22.84M
52.13M
54.71M
-14.68M
Effective tax rate
19.82%
27.36%
27.61%
-13.21%
Other operating expenses
-
-
-430.00K
-570.00K
Net income
59.72M
117.06M
126.96M
98.25M
Net profit margin
3.34%
6.19%
6.81%
4.96%
Earnings per share
-
0.19
-
-
Interest and investment income
-
9.56M
-
36.00M
Interest expense
-153.59M
-141.43M
-156.07M
-107.99M
Net interest expenses
-153.59M
-131.88M
-156.07M
-71.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
404.97M
414.24M
484.03M
422.88M
Gain or loss from assets sale
-
732.00K
-
2.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer